眾業達(002441.SZ):一季度與施耐德簽署了多份分銷協議
格隆匯 3 月 23日丨眾業達(002441.SZ)公佈,2021年第一季度,公司及子公司與同一交易對手施耐德電氣(中國)有限公司及其關聯公司(以下合稱“施耐德”)簽署了多份《分銷協議》、相關設備/產品的採購合同,其中:前述分銷協議為2021年度公司及子公司向施耐德採購的框架協議,採購目標金額合計325,223.2萬元(不含税),具體採購金額以日常實際採購為準;相關設備/產品的採購合同為2021年1月1日至公吿日公司向施耐德實際採購合同,涉及合同金額為1341.88萬元(含税),該金額未包含在分銷協議的採購目標金額中。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.